³·Àº ·ù¸¶Æ¼½º°üÀý¿° Áúº´È°¼ºµµ¸¦ µ¿¹ÝÇÑ ºÒÀÀ¼º Felty ÁõÈıº¿¡¼ RituximabÀÇ Ä¡·á 1¿¹
Treatment with Rituximab in a Patient with Refractory Felty Syndrome and Low Rheumatoid Arthritis Disease Activity: A Case Report
´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö 2014³â 21±Ç 1È£ p.36 ~ p.39
À强Çý(Chang Sung-Hae) - ¼¿ï´ëÇб³º´¿ø ³»°ú
¾çÁö¾Ö(Yang Ji-Ae) - ¼¿ï´ëÇб³º´¿ø ³»°ú
ÀÌ»óÁø(Lee Sang-Jin) - ¼¿ï´ëÇб³º´¿ø ³»°ú
¹ÚÁØ¿ø(Park Jun-Won) - ¼¿ï´ëÇб³º´¿ø ³»°ú
½Å±âö(Shin Ki-Chul) - ¼¿ï´ëÇб³ º¸¶ó¸Åº´¿ø ³»°ú
ÀÌÀººÀ(Lee Eun-Bong) - ¼¿ï´ëÇб³º´¿ø ³»°ú
¼Û¿µ¿í(Song Yeong-Wook) - ¼¿ï´ëÇб³º´¿ø ³»°ú
ÀÌÀº¿µ(Lee Eun-Young) - ¼¿ï´ëÇб³º´¿ø ³»°ú
Abstract
Felty syndrome (FS) is a rare manifestation in rheumatoid arthritis (RA) characterized by neutropenia and spleno-megaly. Treatment for FS is not well established because there has been no randomized controlled study. A few re-cent reports found rituximab effective in patients with re-fractory FS. According to those reports, most patients with RA and FS had active arthritis. Here we report a case of a patient with glucocorticoid dependent and disease-modify-ing anti-rheumatic drugs (DMARDs) refractory FS and qui-escent RA who was successfully treated with rituximab.
Å°¿öµå
Felty syndrome, Rituximab, Rheumatoid ar-thritis
KMID :
0388220140210010036
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)